RU98119523A - COMPOUNDS OF PIPERAZIN AND PIPERIDINE - Google Patents
COMPOUNDS OF PIPERAZIN AND PIPERIDINEInfo
- Publication number
- RU98119523A RU98119523A RU98119523/04A RU98119523A RU98119523A RU 98119523 A RU98119523 A RU 98119523A RU 98119523/04 A RU98119523/04 A RU 98119523/04A RU 98119523 A RU98119523 A RU 98119523A RU 98119523 A RU98119523 A RU 98119523A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- group
- compound
- salts
- phenyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 17
- GLUUGHFHXGJENI-UHFFFAOYSA-N piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000005842 heteroatoms Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- -1 cyano, aminocarbonyl Chemical group 0.000 claims 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Claims (6)
в которой A обозначает гетероциклическую группу с 5-7 атомами в кольце, содержащую 1-3 гетероатомами из группы O, N и S; R1 обозначает водород или фтор; R2 обозначает C1-4алкил, C1-4алкокси или оксогруппу, и p равен 0, 1 или 2; Z обозначает углерод или азот, и пунктирная линия обозначает простую связь, когда Z является азотом, и простую или двойную связь, когда Z является углеродом; R3 и R4 независимо друг от друга обозначают водород или C1-4алкил; n равен 1 или 2; R5 обозначает галоген, гидрокси, C1-4алкокси или C1-4алкил, и q равен 0, 1, 2 или 3; Y обозначает фенил, фуранил или тиенил, которые могут быть замещены 1-3 заместителями из группы гидрокси, галоген, C1-4алкокси, C1-4алкил, циано, аминокарбонил, моно- иди ди-C1-4алкиламинокарбонил; и их соли.1. The compounds of formula a
in which A denotes a heterocyclic group with 5-7 atoms in the ring, containing 1-3 heteroatoms from the group O, N and S; R 1 denotes hydrogen or fluorine; R 2 is C 1-4 alkyl, C 1-4 alkoxy or oxo, and p is 0, 1 or 2; Z is carbon or nitrogen, and the dotted line indicates a single bond when Z is nitrogen, and a single or double bond when Z is carbon; R 3 and R 4 independently of one another denote hydrogen or C 1-4 alkyl; n is 1 or 2; R 5 is halogen, hydroxy, C 1-4 alkoxy or C 1-4 alkyl, and q is 0, 1, 2 or 3; Y is phenyl, furanyl or thienyl, which may be substituted by 1 to 3 substituents from the group of hydroxy, halogen, C 1-4 alkoxy, C 1-4 alkyl, cyano, aminocarbonyl, mono di di C 1-4 alkylaminocarbonyl; and their salts.
в которой R1 и (R2)p имеют значения, указанные в п.1, n равен 1, R3, R4, (R5)q, Y и Z имеют значения, указанные в пункте 1, и их соли.
in which R 1 and (R 2 ) p have the meanings indicated in item 1, n is 1, R 3 , R 4 , (R 5 ) q, Y and Z have the meanings indicated in item 1 and their salts.
подвергают взаимодействию с соединением формулы
в которой X является отщепляемой группой; или b) соединение формулы n подвергают взаимодействию с соединением формулы
и формальдегидом; или c) соединение формулы n подвергают взаимодействию с соединением формулы
с последующим восстановлением кетогруппы; или d) соединение формулы
подвергают взаимодействию с соединением Y-Br; или e) соединение формулы
подвергают взаимодействию с соединением формулы
B(OH)2-Y
причем символы, используемые в этих формулах, имеют значения, указанные в п.1.6. The method of producing compounds claimed in claim 1, which is that a) a compound of the formula n
subjected to interaction with the compound of the formula
in which X is a leaving group; or b) a compound of formula n is reacted with a compound of formula
and formaldehyde; or c) a compound of formula n is reacted with a compound of formula
with the subsequent restoration of ketogroup; or d) a compound of the formula
subjected to interaction with the compound Y-Br; or e) a compound of the formula
subjected to interaction with the compound of the formula
B (OH) 2 -Y
moreover, the symbols used in these formulas have the meanings indicated in paragraph 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96200864.5 | 1996-03-29 | ||
EP96200864 | 1996-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98119523A true RU98119523A (en) | 2000-10-20 |
RU2178414C2 RU2178414C2 (en) | 2002-01-20 |
Family
ID=8223832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98119523/04A RU2178414C2 (en) | 1996-03-29 | 1997-03-20 | Derivatives of piperazine and piperidine and method of their synthesis |
Country Status (25)
Country | Link |
---|---|
US (1) | US6225312B1 (en) |
EP (1) | EP0889889B1 (en) |
JP (1) | JP3989554B2 (en) |
CN (1) | CN1100055C (en) |
AT (1) | ATE340173T1 (en) |
AU (1) | AU708053B2 (en) |
BR (1) | BRPI9708389B8 (en) |
CA (1) | CA2250347C (en) |
CZ (1) | CZ294413B6 (en) |
DE (1) | DE69736704T2 (en) |
DK (1) | DK0889889T3 (en) |
ES (1) | ES2271967T3 (en) |
HU (1) | HU227454B1 (en) |
IL (1) | IL126187A0 (en) |
NO (1) | NO320970B1 (en) |
NZ (1) | NZ331860A (en) |
PL (1) | PL189256B1 (en) |
PT (1) | PT889889E (en) |
RU (1) | RU2178414C2 (en) |
SK (1) | SK285119B6 (en) |
TR (1) | TR199801942T2 (en) |
TW (1) | TW422846B (en) |
UA (1) | UA52656C2 (en) |
WO (1) | WO1997036893A1 (en) |
ZA (1) | ZA972639B (en) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0900792B1 (en) * | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
TW530054B (en) * | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
EP1146045A1 (en) * | 1998-06-30 | 2001-10-17 | Eli Lilly And Company | Piperidine derivatives having effects on serotonin related systems |
US6436964B1 (en) * | 1998-06-30 | 2002-08-20 | Eli Lilly And Company | Piperidine derivatives having effects on serotonin related systems |
UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
PT1204654E (en) * | 1999-07-29 | 2003-11-28 | Lilly Co Eli | SEROTONIN 5-HT2C RECEPTOR AGONIST BENZOFURILPIPERAZINES |
JP2003506370A (en) | 1999-07-29 | 2003-02-18 | イーライ・リリー・アンド・カンパニー | Benzofurylpiperazine serotonin agonist |
KR100791799B1 (en) | 2000-05-12 | 2008-01-04 | 솔베이 파마슈티칼스 비. 브이 | Piperazine and piperidine compounds, and preparation thereof |
EP1284731A1 (en) * | 2000-05-12 | 2003-02-26 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
ATE255578T1 (en) * | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | PIPERAZINE AND PIPERIDINE COMPOUNDS |
AR034206A1 (en) * | 2001-02-16 | 2004-02-04 | Solvay Pharm Bv | A PROCEDURE FOR THE PREPARATION OF MESILATES OF PIPERAZINE DERIVATIVES AND SUCH MESILATES |
JP5080716B2 (en) * | 2001-07-20 | 2012-11-21 | サイコジェニックス・インコーポレーテッド | Treatment of attention deficit / hyperactivity disorder |
DK1562918T3 (en) * | 2002-11-08 | 2008-05-05 | Hoffmann La Roche | Substituted benzoxazinones and uses thereof |
GB0316915D0 (en) * | 2003-07-18 | 2003-08-20 | Glaxo Group Ltd | Compounds |
ES2232292B1 (en) * | 2003-07-30 | 2006-11-01 | Laboratorios Del Dr. Esteve, S.A. | SULFONAMIDIC COMPOUNDS DERIVED FROM BENZOXAZINONA, ITS PREPARATION AND USE AS MEDICATIONS. |
AR045362A1 (en) * | 2003-08-18 | 2005-10-26 | Solvay Pharm Bv | STABLE CRYSTALLINE FORM OF BIFEPRUNOX MESILATE (MONOMETANSULFONATE 7- [4 - ([1,1- BIFENIL] -3- ILMETIL) -1- PIPERAZINIL] - 2- (3H) -BENZOXAZOLONA |
US7435738B2 (en) | 2003-08-18 | 2008-10-14 | Solvay Pharmaceuticals, Inc. | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) |
AR048112A1 (en) * | 2004-03-25 | 2006-03-29 | Solvay Pharm Bv | DERIVATIVES OF 1- (2H-1-BENZOPIRAN-2-ON-8-IL) -PIPERAZINE FOR PAIN TREATMENT |
US20050215551A1 (en) * | 2004-03-25 | 2005-09-29 | Solvay Pharmaceuticals B.V. | 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders |
AR049478A1 (en) | 2004-03-25 | 2006-08-09 | Solvay Pharm Bv | A PROCEDURE FOR THE PREPARATION OF 3-AMINO-8- (1-PIPERAZINIL) -2H-1-BENZOPIRAN-2-ONA. SALTS AND HYDRATES AND PHARMACEUTICAL COMPOSITIONS. |
US7405216B2 (en) | 2004-08-18 | 2008-07-29 | Solvay Pharmaceuticals, B.V. | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) |
US7371769B2 (en) | 2004-12-07 | 2008-05-13 | Solvay Pharmaceuticals B.V. | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
US20060122247A1 (en) | 2004-12-08 | 2006-06-08 | Solvay Pharmaceuticals B.V. | Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
US7423040B2 (en) | 2005-02-18 | 2008-09-09 | Irene Eijgendaal | Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same |
US7964604B2 (en) | 2005-02-18 | 2011-06-21 | Solvay Pharmaceuticals B.V. | Bifeprunox mesylate maintenance dose compositions and methods for using the same |
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
AR058022A1 (en) * | 2005-08-22 | 2008-01-23 | Solvay Pharm Bv | DERIVATIVES OF BENZOOXAZOLES, PHARMACEUTICAL COMPOSITIONS AND ITS USE FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS. |
US7750013B2 (en) | 2005-08-22 | 2010-07-06 | Solvay Pharmaceuticals, B.V. | N-oxides as prodrugs of piperazine and piperidine derivatives |
ES2318783T3 (en) * | 2005-08-22 | 2009-05-01 | Solvay Pharmaceuticals B.V. | N-OXIDES AS PROPHARMACES OF PIPERAZINE AND PIPERADINE DERIVATIVES. |
US7786126B2 (en) | 2006-06-16 | 2010-08-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising SLV308 and a dopamine agonist |
US8106056B2 (en) | 2006-06-16 | 2012-01-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising bifeprunox and a dopamine agonist |
BRPI0715445A2 (en) * | 2006-08-31 | 2014-05-13 | Solvay Pharm Bv | USE OF A BIFEPRUNOX COMPOUND, AND TITLE KIT |
TW200840566A (en) * | 2006-12-22 | 2008-10-16 | Esteve Labor Dr | Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
US20080299217A1 (en) * | 2007-06-01 | 2008-12-04 | Protia, Llc | Deuterium-enriched bifeprunox |
US20090324569A1 (en) * | 2007-11-21 | 2009-12-31 | Decode Genetics Ehf | Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
WO2009090177A1 (en) * | 2008-01-15 | 2009-07-23 | Solvay Pharmaceuticals B.V. | Bifeprunox derivatives |
CN103467554A (en) | 2008-02-05 | 2013-12-25 | 哈博生物科学公司 | Pharmaceutical solid state forms |
US8853202B2 (en) * | 2008-11-04 | 2014-10-07 | Chemocentryx, Inc. | Modulators of CXCR7 |
MX2011004490A (en) * | 2008-11-04 | 2011-07-20 | Chemocentryx Inc | Modulators of cxcr7. |
US20110014121A1 (en) * | 2008-11-04 | 2011-01-20 | Chemocentryx, Inc. | Modulators of cxcr7 |
WO2010151689A1 (en) | 2009-06-25 | 2010-12-29 | Alkermes, Inc. | Heterocyclic compounds for the treatment of neurological and psychological disorders |
EP2445343B1 (en) * | 2009-06-25 | 2021-08-04 | Alkermes Pharma Ireland Limited | Prodrugs of nh-acidic compounds |
WO2011023796A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Healthcare Products B.V. | Bifeprunox for treating addiction |
PL395469A1 (en) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Indolamines derivatives for the treatment of diseases of the central nervous system |
DK2925745T3 (en) * | 2012-11-29 | 2018-07-23 | Chemocentryx Inc | CXCR7 antagonists |
BR112019003811A2 (en) | 2016-08-26 | 2019-05-21 | Exciva Ug (Haftungsbeschränkt) | pharmaceutical composition, method for increasing the nmda receptor antagonist plasma levels in a subject in need thereof, method for treating a disease or disorder in a subject in need thereof and use of the composition |
CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
JP2022512367A (en) | 2018-12-12 | 2022-02-03 | ケモセントリックス,インコーポレイティド | CXCR7 inhibitor for cancer treatment |
CN114246869A (en) * | 2022-01-18 | 2022-03-29 | 万宜合药业(海南)有限责任公司 | Anti-tumor activity and application of bifeprunox and derivatives thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2263211A1 (en) * | 1972-12-23 | 1974-07-04 | Boehringer Sohn Ingelheim | NEW ARYLPIPERAZINE AND PROCESS FOR THEIR PRODUCTION |
JPS5777676A (en) | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
EP0185429A1 (en) | 1984-12-21 | 1986-06-25 | Duphar International Research B.V | New bicyclic heteroaryl piperazines |
DE3586794T2 (en) * | 1984-12-21 | 1993-05-27 | Duphar Int Res | MEDICINAL PRODUCTS WITH PSYCHOTROPER EFFECT. |
ATE82281T1 (en) * | 1986-02-27 | 1992-11-15 | Duphar Int Res | ARYL-SUBSTITUTED(N-PIPERIDINYL)METHYL AND (NPIPERAZINYL)METHYLAZOLES WITH ANTI-SYCHOTIC ACTIVITY. |
FR2602771B1 (en) * | 1986-08-12 | 1988-11-04 | Rhone Poulenc Sante | NOVEL BENZYL-4 PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US5153206A (en) | 1988-12-02 | 1992-10-06 | Pfizer Inc. | Arylpiperidine derivatives |
US5242933A (en) | 1990-07-10 | 1993-09-07 | Adir Et Compagnie | Piperidine, tetrahydropyridine and pyrrolidine compounds |
US5240942A (en) | 1990-07-10 | 1993-08-31 | Adir Et Compagnie | Piperidine, tetrahydropyridine and pyrrolidine compounds |
US5260317A (en) | 1990-07-10 | 1993-11-09 | Adir Et Compagnie | Piperidine, tetrahydropyridine and pyrrolidine compounds |
FR2664592B1 (en) * | 1990-07-10 | 1994-09-02 | Adir | NOVEL DERIVATIVES OF PIPERIDINE, TETRAHYDROPYRIDINE AND PYRROLIDINE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
US5569659A (en) | 1991-09-11 | 1996-10-29 | Mcneilab, Inc. | 4-arylpiperazines and 4-arylpiperidines |
NZ240863A (en) * | 1991-09-11 | 1995-04-27 | Mcneilab Inc | Substituted 4-aryl piperidine and 4-aryl piperazine derivatives, preparation and pharmaceutical compositions thereof |
US5436246A (en) * | 1992-09-17 | 1995-07-25 | Merrell Dow Pharmaceuticals Inc. | Serotonin receptor agents |
DK148392D0 (en) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocyclic Compounds |
GB9314758D0 (en) | 1993-07-16 | 1993-08-25 | Wyeth John & Brother Ltd | Heterocyclic derivatives |
EP0650964A1 (en) | 1993-11-02 | 1995-05-03 | Duphar International Research B.V | 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives |
-
1997
- 1997-03-20 TR TR1998/01942T patent/TR199801942T2/en unknown
- 1997-03-20 RU RU98119523/04A patent/RU2178414C2/en not_active IP Right Cessation
- 1997-03-20 BR BRPI9708389A patent/BRPI9708389B8/en not_active IP Right Cessation
- 1997-03-20 CZ CZ19983068A patent/CZ294413B6/en not_active IP Right Cessation
- 1997-03-20 NZ NZ331860A patent/NZ331860A/en not_active IP Right Cessation
- 1997-03-20 CN CN97193520A patent/CN1100055C/en not_active Expired - Fee Related
- 1997-03-20 PT PT97908288T patent/PT889889E/en unknown
- 1997-03-20 PL PL97329123A patent/PL189256B1/en not_active IP Right Cessation
- 1997-03-20 EP EP97908288A patent/EP0889889B1/en not_active Expired - Lifetime
- 1997-03-20 SK SK1331-98A patent/SK285119B6/en not_active IP Right Cessation
- 1997-03-20 AT AT97908288T patent/ATE340173T1/en active
- 1997-03-20 DK DK97908288T patent/DK0889889T3/en active
- 1997-03-20 US US09/155,608 patent/US6225312B1/en not_active Expired - Lifetime
- 1997-03-20 HU HU9902471A patent/HU227454B1/en not_active IP Right Cessation
- 1997-03-20 CA CA002250347A patent/CA2250347C/en not_active Expired - Fee Related
- 1997-03-20 AU AU20294/97A patent/AU708053B2/en not_active Ceased
- 1997-03-20 JP JP53488697A patent/JP3989554B2/en not_active Expired - Fee Related
- 1997-03-20 ES ES97908288T patent/ES2271967T3/en not_active Expired - Lifetime
- 1997-03-20 UA UA98105745A patent/UA52656C2/en unknown
- 1997-03-20 IL IL12618797A patent/IL126187A0/en not_active IP Right Cessation
- 1997-03-20 DE DE69736704T patent/DE69736704T2/en not_active Expired - Lifetime
- 1997-03-20 WO PCT/EP1997/001461 patent/WO1997036893A1/en active IP Right Grant
- 1997-03-26 ZA ZA9702639A patent/ZA972639B/en unknown
- 1997-03-28 TW TW086104056A patent/TW422846B/en not_active IP Right Cessation
-
1998
- 1998-09-28 NO NO19984533A patent/NO320970B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98119523A (en) | COMPOUNDS OF PIPERAZIN AND PIPERIDINE | |
RU96119782A (en) | DERIVATIVES 7-AMINO-1H-INDOLA | |
RU98117621A (en) | NEW DERIVATIVES OF PIPERASIN AND PIPERIDINE, METHOD FOR PRODUCING THEM, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHOD OF TREATMENT, INTERMEDIATE PRODUCT | |
KR880001597A (en) | Alkylenediamine | |
ATE152445T1 (en) | 3,5-DIOXO-(2H,4H)-1,2,4-TRIAZINE AS 5HT1A LIGAND | |
GB0113233D0 (en) | Chemical compounds | |
ME00108B (en) | Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics | |
RU2002107318A (en) | NEW Phenylpiperazines | |
RU93046499A (en) | METHOD FOR INCREASING THE RELATIVE DENSITY OF POLYAMIDS | |
RU2006137563A (en) | METHOD FOR PRODUCING AMINOPHENOL COMPOUNDS | |
RU2003105902A (en) | METHOD FOR PRODUCING PIPERASIN DERIVATED MESILATES | |
RU99115165A (en) | Method of producing thiazole derivatives | |
YU46699A (en) | Improved method for producing thiazolidinediones, and new thiazolidinediones | |
AR021114A1 (en) | PHOTOSTABILIZATION PROCEDURE OF SOLAR FILTERS DERIVED FROM 1,3,5-TRIAZINE | |
ATE75737T1 (en) | INDENOTHIAZOLE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION. | |
ZA200002207B (en) | Substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
ES466887A2 (en) | A procedure for the preparation of a substitute phenylamidine. (Machine-translation by Google Translate, not legally binding) | |
KR850001194A (en) | compound | |
KR850007588A (en) | Method for preparing β-naphthylalkylamine | |
RU2006119924A (en) | METHODS FOR PRODUCING HEXAN BICYCLO [3.1.0] DERIVATIVES AND INTERMEDIATE COMPOUNDS FOR THIS PURPOSE | |
ES8105981A1 (en) | 4-(Naphthalenyloxy)piperidine Derivatives | |
RU99115082A (en) | DIPHENYLALKYL-TETRAHYDROPYRIDINES, METHOD FOR THEIR RECEPTION AND PHARMACEUTICAL COMPOSITIONS THEM CONTAINING | |
RU2007111957A (en) | PIPERIDINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | |
EP0280841A3 (en) | Organo-silicone compounds and use thereof | |
NZ535476A (en) | 4-(diarylmethyl)-1-piperazinyl derivatives |